Hepatoblastoma
- PMID: 7809507
Hepatoblastoma
Abstract
Hepatoblastoma is the most frequently occurring liver tumor in children, accounting for over 25% pediatric hepatic tumors and nearly 50% of those that are malignant. Histologically, the tumor can be divided into the following six patterns: (1) fetal epithelial; (2) embryonal and fetal epithelial; (3) macrotrabecular; (4) small cell undifferentiated; and (5) mixed epithelial and mesenchymal type with teratoid features or (6) without teratoid features. Immunohistochemical studies display a wide variety of immunostaining with monoclonal antibodies particularly those specific for epithelial-derived components. Tumor cytogenetics show a high incidence of trisomy 20 and trisomy of all or part of chromosome 2. The developing liver displays many features similar to those seen in hepatoblastoma, including uniform hepatocytes and cords two cells thick separated by sinusoids displaying hematopoiesis. Hepatoblastomas display only minimal ductular differentiation, similar to the fetal development of the liver that does not display significant ductular development until well into the second trimester.
Similar articles
-
Activation of beta-catenin in epithelial and mesenchymal hepatoblastomas.Oncogene. 2000 Jan 27;19(4):498-504. doi: 10.1038/sj.onc.1203356. Oncogene. 2000. PMID: 10698519
-
Small cells in hepatoblastoma lack "oval" cell phenotype.Mod Pathol. 2003 Sep;16(9):930-6. doi: 10.1097/01.MP.0000086486.52370.81. Mod Pathol. 2003. PMID: 13679457
-
Immunohistochemical evaluation of hepatoblastomas with use of the hepatocyte-specific marker, hepatocyte paraffin 1, and the polyclonal anti-carcinoembryonic antigen.Mod Pathol. 1998 Oct;11(10):934-8. Mod Pathol. 1998. PMID: 9796718
-
An approach to handling pediatric liver tumors.Am J Clin Pathol. 1998 Apr;109(4 Suppl 1):S67-72. Am J Clin Pathol. 1998. PMID: 9533750 Review.
-
Fetal and neonatal hepatic tumors.J Pediatr Surg. 2007 Nov;42(11):1797-803. doi: 10.1016/j.jpedsurg.2007.07.047. J Pediatr Surg. 2007. PMID: 18022426 Review.
Cited by
-
FAK Inhibition Decreases Hepatoblastoma Survival Both In Vitro and In Vivo.Transl Oncol. 2013 Apr;6(2):206-15. doi: 10.1593/tlo.12505. Epub 2013 Apr 1. Transl Oncol. 2013. PMID: 23544173 Free PMC article.
-
Congenital hepatoblastoma in a neonatal alpaca cria.Can Vet J. 2001 Nov;42(11):872-4. Can Vet J. 2001. PMID: 11708207 Free PMC article.
-
Histological and immunohistochemical study of hepatoblastoma: correlation with tumour behaviour and survival.J Gastrointest Oncol. 2018 Apr;9(2):326-337. doi: 10.21037/jgo.2018.01.08. J Gastrointest Oncol. 2018. PMID: 29755772 Free PMC article.
-
CXCL5 as an autocrine or paracrine cytokine is associated with proliferation and migration of hepatoblastoma HepG2 cells.Oncol Lett. 2017 Dec;14(6):7977-7985. doi: 10.3892/ol.2017.7236. Epub 2017 Oct 20. Oncol Lett. 2017. PMID: 29344240 Free PMC article.
-
Identification of differentially expressed genes, lncRNAs and miRNAs which are associated with tumor malignant phenotypes in hepatoblastoma patients.Oncotarget. 2017 Oct 31;8(57):97554-97564. doi: 10.18632/oncotarget.22181. eCollection 2017 Nov 14. Oncotarget. 2017. PMID: 29228631 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Medical